Learn how NAD+ and Ketamine may reduce Long COVID symptoms
*IV Ketamine, NR, and NAD+ have been used clinically off-label for decades. They are not FDA approved for the treatment of any psychiatric or pain condition. All medical treatments carry risks and benefits that you must discuss with a doctor at Clarus Health to learn if these therapies are right for you.
Long COVID occurs in roughly 50% of COVID survivors. Symptoms can be troubling for my patients, especially the brain fog and fatigue. Learn how NAD+ can help reduce long COVID symptoms, and how its effects can be augmented with IV Ketamine therapy.
Long COVID refers to dysfunction of multiple organ systems after resolution of SARS-CoV2 infection (COVID). Usually, symptoms should have resolved by 4 weeks. If COVID symptoms persist longer than 12 weeks, roughly 70% of patients will still have symptoms within a year. There are many symptoms of long COVID, across your organs, including:
Many of these symptoms overlap with chronic fatigue syndrome myalgic encephalomyelitis (ME/CFS), suggesting they may be related.
NAD+ is a critical molecule responsible for energy metabolism and DNA repair found in every cell in your body. NAD+ is vital to health and aging, but appears impacted by COVID:
When NAD+ is depleted, it reduces the function of a critical enzyme called SIRT1. Reduced SIRT1 function may contribute to serious COVID symptoms, especially in those at highest risk, like the elderly and those with diabetes or obesity. Furthermore, SIRT1 imbalances can contribute to the immune system dysfunction that may cause long COVID.
NAD+ is also critical to healing from other viral infections. There is increasing study of its effects in those at greatest risk, such as the elderly and those with diabetes and heart conditions. The good news is that NAD+ is very well tolerated in those with long COVID.
When NAD+ has been depleted in our bodies, our brain is one of the first organs to come under stress. This is because the brain requires a tremendous amount of energy. IV NAD+ supplementation is a promising modality for treating brain fog and chronic fatigue. In fact, NAD+ supplementation has also been studied specifically in patients with ME/CFS.
The neuroinflammation from long COVID may cause depression and other mental health conditions. Specifically, this neuroinflammation is called reactive gliosis. Ketamine has anti-inflammatory properties that may contribute to its anti-depressive effects. In fact, depression becomes harder to treat as the inflammation increases. Fortunately, IV Ketamine can reduce these specific inflammatory agents (called cytokines).
IV Ketamine can be a powerful option for those suffering with depression from long COVID.
Clarus Health uses a proprietary combination of NAD+ and Ketamine infusions for a synergistic long COVID therapy. Schedule a free consultation with Clarus Health to learn if NAD+ and IV Ketamine may be effective in treating long haul COVID for you or a loved one.
Dr. Kaveh is a Stanford and Harvard-trained anesthesiologist and integrative medicine specialist. He has over 1,000,000 followers on social media and has guided hundreds of patients throughout transformative healing experiences. He is an authority on Ketamine, NAD, SGB, and genomics-guided therapies. He is a continuing medical education lecturer in the Bay Area.
